Moderate lifetime marijuana smoking not associated with lung function decline
the ONA take:
According to a new study published online in the journal Annals of the American Thoracic Society, researchers at Emory University in Atlanta, Georgia, have found that moderate lifetime marijuana use is associated with airway inflammation, but not significant changes in lung function.
For the study, researchers analyzed data from the National Health and Nutrition Examination Survey (NHANES). They identified over 5,000 adult survey participants with data on recent marijuana use and respiratory symptoms. Results showed that nearly 60% reported using marijuana at least once during their lifetime, and about 12% said they had used marijuana in the last month.
Among the 3,000 adult participants who had patterns of lifetime marijuana use, cumulative exposure of less than 20 joint-years was not linked with significant changes in lung function; however, more than 20 joint-years of marijuana exposure was associated with clinically significant changes in lung function.
The results do not show whether this change in lung function represents early lung function decline like that of long-term tobacco use. Researchers also found that marijuana smoking increased respiratory irritation, but the study could not determine whether those symptoms were permanent.
The researchers note that they did not assess an association between marijuana use and cancer.
Moderate lifetime marijuana use is associated with airway inflammation, but not significant changes in lung function.
Sign Up for Free e-newsletters
- Distress, Neuroticism Predict Long-term Emotional Distress After Cancer Diagnosis
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Patient Satisfaction Ratings Can Be Negatively Impacted by Nurse Staffing Ratio
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Bacteria in Probiotics Carry Potential Risks for Immunocompromised Patients
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- Overall Survival Prolonged With HIPEC + Cytoreductive Surgery for Gastric Cancer
- Better Postoperative Outcomes With RAMIE for Esophageal Cancer
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|